side (n¼8), and in ureters on both sides (n¼10) and the remaining (n¼6 pts) on one side in the kidney, another side in the ureter. RESULTS: Mean stone size of both renal unit and ureter ranged from 8 to 22 (14.6 mm) and 5-12 (7.2 mm) respectively. Mean operating time was 98 minutes. Mean hospital stay was 2.4 days. Stone free rate was 83.3% after a single session. Complications included ureteric perforation and extravasation (n¼2), postoperatively, moderate hematuria (n¼4) and febrile UTI (n¼2) requiring intravenous antibiotics. Four patients (16.6%) needed auxiliary procedures for complete recovery of the residual stones in the form of ESWL (n¼3) and PCNL (n¼1) CONCLUSIONS: Bilateral simultaneous retrograde intrarenal surgery in children is safe and feasible with good stone clearance and low morbidities. It eliminates the need for repeated anesthesia and psychological stress associated with multiple interventions. However, this practice should be restricted to tertiary referral centers with high stone volume.
INTRODUCTION AND OBJECTIVES: The use of retrograde intrarenal surgery (RIRS) in children for management of upper tract urinary stones is on the rise. This is best accomplished by flexible ureteroscopy and laser lithotripsy; however, this might not be feasible in centers of limited resources. We present our experience with RIRS using semirigid ureteroscopy with the help of positional maneuvers to facilitate success of RIRS METHODS: Fifty children underwent RIRS and laser lithotripsy with the aid of series of kidney position manipulations including: manually uplifting the kidney by flank elevation, pushing the kidney down by anterior abdominal wall pressure, rotating the kidney medially or laterally by manual pressure in the lateral flank or midline, placing the patient in Trendelenburg or reverse Trendelenburg position, altering respiratory rate and tidal volume and use of syringe pressurized irrigation or suction to alter stone position and help getting stone in the target zone of the ureteroscopy.
RESULTS: Twenty seven children had a renal pelvic stone, 12 with upper calyceal stones, 7 with middle calyceal stones and 4 with lower calyceal stones. Forty two (84%) patients were rendered stone free with the help of positional manipulation described. No intraoperative complication except for mild extravasation in two cases. Mean operative time was 52 minutes. Five patients of febrile UTI and two cases of moderate hematuria successfully managed conservatively in postoperative period.
CONCLUSIONS: Positional manipulation for RIRS using semirigid ureteroscopy in children is a successful and cost effective approach with low complication rates. However, this approach might not be possible when ureteric or pelvicalyceal anatomy is unfavorable.
Source of Funding: None

MP68-09 CONTINUING ASPIRIN DOES NOT INCREASE BLOOD LOSS FROM PERCUTANEOUS NEPHROLITHOTOMY
Timothy Tran*, Egor Parkhomenko, Julie Thai, Kyle Blum, Mantu Gupta, New York, NY INTRODUCTION AND OBJECTIVES: Patients with vascular or cardiac disease may benefit from continuing antiplatelet therapy during surgery. Percutaneous nephrolithotomy (PCNL) is a transparenchymal procedure that can be associated with significant bleeding. Recent studies have demonstrated safety with continuing aspirin during PCNL. However, these studies were notable for patients having large postoperative nephrostomy tubes that may have provided additional hemostatic control. Here, we evaluated our experience with continuing aspirin in patients undergoing PCNL.
METHODS: All patients that underwent PCNL over the last 3 years were evaluated. Hematocrit levels were recorded preoperatively, one hour after surgery and on postoperative day 1. Clinical and demographic parameters were recorded. Statistical difference was assessed using Student's t-test and chi-square test.
RESULTS: 218 patients underwent PCNL during this time period. 20 patients continued aspirin through surgery and an additional 20 stopped aspirin one week prior to their procedure. No difference in mean hematocrit decrease was noted between patients that never took aspirin, those that stopped and those that continued on postoperative day 0 ( Joshua Ebel*, Bodo Knudsen, Columbus, OH INTRODUCTION AND OBJECTIVES: The rates of heart disease and nephrolithiasis continue to increase in the United States. As more patients on aspirin for secondary prevention present with large kidney stones, urologists are increasingly faced with the decision to proceed with the less effective but lower risk ureteroscopy or the higher risk but more effective percutaneous nephrolithotomy (PCNL). Leavitt, Smith, and Okeke recently published their experience performing PCNLs on seventeen patients continued on aspirin perioperatively and concluded that the procedure was safe. We wish to add our center's experience to this body of knowledge.
METHODS: We retrospectively reviewed our single center, single surgeon, experience of 199 PCNLs performed between January 2013 and September 2016. Hemoglobin pre-and post-operatively was recorded as were the relevant related variables of age, sex, BMI, operative duration, skin-to-stone distance, stone size, aspirin dose, aspirin indication, number of blood transfusions, and Clavien-Dindo complication classification. Correlations between hemoglobin and explanatory variables were then explored with linear regression and the Wilcoxon rank-sum test.
RESULTS: Of the 199 PCNLs performed at our institution in the range of our study, 27 procedures on 23 patients were conducted without discontinuing aspirin perioperatively. Coronary artery disease was the most common indication for aspirin use. In 24 cases, the patient was on 81 mg of aspirin perioperatively with the remaining three patients on 325 mg of aspirin daily. The average patient experienced a 1.3 g/dl drop in hemoglobin perioperatively. The largest drop was 4.1 g/dl, but the lowest post-operative hemoglobin was 8.2 g/dl. No significant associations were found between hemoglobin decline and age, sex, BMI, operative duration, skin-to-stone distance, or stone size. There were no Clavien-Dindo grade III or higher complications in the course of our review, and no patients required a blood transfusion or embolization. In one case, a patient required a three day inpatient stay following stent removal for continuous bladder irrigation after developing gross hematuria but this resolved spontaneously.
CONCLUSIONS: In our single center experience, PCNLs performed on patients taking aspirin perioperatively were not associated Vol. 197, No. 4S, Supplement, Monday, May 15, 2017 THE JOURNAL OF UROLOGY â e921 with the need for blood transfusion nor the occurrence of high-grade complications. It is our experience that this practice is safe when performed by expert hands. We performed a prospective, randomized trial to assess the safety and efficacy of Tisseelâ, Tachosilâ in tubeless percutaneous nephrolithotomy.
Source of
METHODS: A total of 75 patients undergoing tubeless percutaneous nephrolithotomy(PCNL) were randomized to receive Tisseelâ, Tachosilâ and control at the end of the procedure. The three groups were comparable in age, sex, height, weight, body mass index, stone size and in metabolic and anatomic features. (Table 1 ) After stone clearance, at the end of the procedure, the nephrostomy tract was closed with a deep #1-0 silk stitch in group 1 patients. Tisseel sealant was loaded and introduced into nephrostomy tract in group 2 patients. In group 3 patients, Tachosil was dipped in contrast medium, rolled like a cigarette and inserted through the nephrostomy tract. The primary end of this study was to evaluate the efficacy of sealants in PCNL. And, the secondary end was compliance of sealants by pain and hospital stay.
RESULTS: There were no differences in the hemoglobin decrease and blood transfusion requirement among the groups during the operation. (Table 2 ) Serial changes in hemoglobin were comparable among the groups during the hospital stay. (Table 3) There was no significant difference in the extent of postoperative perirenal hematoma formation. (p¼0.694) (Table 4) The average visual analog scale pain score on postoperative 1 day were 1.92AE2.47, 1.72AE1.67 and 1.48AE1.73 respectively in each group. (p¼0.378) The hospital stay were 2.28AE0.93, 2.00AE0.96, and 2.04AE0.99 (p¼0.579) in each group. No long-term sequelae were observed in the median follow up period of 24 months in any patient.
CONCLUSIONS: This study indicates that the hemostatic agents in standard tubeless PCNL were not expected to be effective or mandatory. Additional wide, prospective, randomized studies are required to get more fine clinical evidence for the hemostatic agent usage in tubeless PCNL.
Source of Funding: none
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